Patents by Inventor Bagna Bao

Bagna Bao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CARBONIC ANHYDRASE TARGETING AGENTS AND METHODS OF USING SAME
    Publication number: 20220023277
    Abstract: The invention provides agents that target carbonic anhydrase, which can be used as imaging agents or therapeutic agents. The agents can be used to image tumor hypoxia as well as other physiological processes in a subject.
    Type: Application
    Filed: July 9, 2021
    Publication date: January 27, 2022
    Inventors: Kevin Groves, Bagna Bao
  • Carbonic anhydrase targeting agents and methods of using same
    Patent number: 11059802
    Abstract: The invention provides agents that target carbonic anhydrase, which can be used as imaging agents or therapeutic agents. The agents can be used to image tumor hypoxia as well as other physiological processes in a subject.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: July 13, 2021
    Assignee: VisEn Medical, Inc.
    Inventors: Kevin Groves, Bagna Bao
  • CARBONIC ANHYDRASE TARGETING AGENTS AND METHODS OF USING SAME
    Publication number: 20190300501
    Abstract: The invention provides agents that target carbonic anhydrase, which can be used as imaging agents or therapeutic agents. The agents can be used to image tumor hypoxia as well as other physiological processes in a subject.
    Type: Application
    Filed: February 27, 2019
    Publication date: October 3, 2019
    Inventors: Kevin Groves, Bagna Bao
  • Carbonic anhydrase targeting agents and methods of using same
    Patent number: 10221159
    Abstract: The invention provides agents that target carbonic anhydrase, which can be used as imaging agents or therapeutic agents. The agents can be used to image tumor hypoxia as well as other physiological processes in a subject.
    Type: Grant
    Filed: May 9, 2012
    Date of Patent: March 5, 2019
    Assignee: VisEn Medical, Inc.
    Inventors: Kevin Groves, Bagna Bao
  • Carbonic Anhydrase Targeting Agents and Methods of Using Same
    Publication number: 20120321563
    Abstract: The invention provides agents that target carbonic anhydrase, which can be used as imaging agents or therapeutic agents. The agents can be used to image tumor hypoxia as well as other physiological processes in a subject.
    Type: Application
    Filed: May 9, 2012
    Publication date: December 20, 2012
    Inventors: Kevin Groves, Bagna Bao
  • Gamma lactams as prostaglandin agonists and use thereof
    Patent number: 7419999
    Abstract: 1,2-substituted 5-pyrrolidinone compounds are provided, and methods of treatment and pharmaceutical composition that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing preterm labor, dysmenorrhea, asthma, hypertension, infertility or fertility disorder, undesired blood clotting, preeclampsia or eclampsia, an eosinophil disorder, sexual dysfunction, osteporosis and other destructive bone disease or disorder, renal dysfunction, an immune deficiency disorder, dry eye, ichthyosis, elevated intraocular pressure, sleep disorder, or gastric ulcer, inflammatory disorders and other diseases and disorders associated with the prostaglandin family of compounds.
    Type: Grant
    Filed: June 9, 2003
    Date of Patent: September 2, 2008
    Assignee: Applied Research Systems ARS Holding N.V.
    Inventors: Gian Luca Araldi, Adulla P. Reddy, Zhong Zhao, Sean D. McKenna, Bagna Bao
  • Gamma lactams as prostaglandin agonists and use thereof
    Publication number: 20050288357
    Abstract: 1,2-substituted 5-pyrrolidinone compounds are provided, and methods of treatment and pharmaceutical composition that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing preterm labor, dysmenorrhea, asthma, hypertension, infertility or fertility disorder, undesired blood clotting, preeclampsia or eclampsia, an eosinophil disorder, sexual dysfunction, osteporosis and other destructive bone disease or disorder, renal dysfunction, an immune deficiency disorder, dry eye, ichthyosis, elevated intraocular pressure, sleep disorder, or gastric ulcer, inflammatory disorders and other diseases and disorders associated with the prostaglandin family of compounds.
    Type: Application
    Filed: June 9, 2003
    Publication date: December 29, 2005
    Applicant: Applied Research Systems ARS Holding N.V.
    Inventors: Gian Araldi, Adulla Reddy, Zhong Zhao, Sean McKenna, Bagna Bao